Biopharmaceutical revenue - statutory health insurance market Germany 2014
This statistic shows a distribution of revenues of biopharmaceuticals on the statutory health insurance market in Germany as of 2014, by patent status. That year, the revenue generated by biosimilars at pharmacy retail prices on the statutory health insurance market amounted to roughly 100 million euros.